ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,480,000 | -80.7% | 455,000 | -57.9% | 0.00% | -80.0% |
| Q2 2019 | $12,865,000 | +133.4% | 1,082,000 | +2.9% | 0.01% | +150.0% |
| Q1 2019 | $5,512,000 | +66.3% | 1,052,000 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $3,314,000 | -34.4% | 1,052,000 | +26.0% | 0.00% | 0.0% |
| Q3 2018 | $5,052,000 | +89.4% | 835,100 | +65.9% | 0.00% | +50.0% |
| Q2 2018 | $2,668,000 | -8.6% | 503,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,920,000 | +65.7% | 503,400 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,762,000 | -0.3% | 503,400 | +3.9% | 0.00% | 0.0% |
| Q3 2017 | $1,768,000 | +44.1% | 484,500 | -1.3% | 0.00% | 0.0% |
| Q2 2017 | $1,227,000 | +3.2% | 490,700 | +11.4% | 0.00% | 0.0% |
| Q1 2017 | $1,189,000 | -3.6% | 440,400 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $1,234,000 | -29.6% | 425,600 | -0.2% | 0.00% | -50.0% |
| Q3 2016 | $1,752,000 | +30.7% | 426,300 | +0.6% | 0.00% | +100.0% |
| Q2 2016 | $1,340,000 | – | 423,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |